Search research articles
Contact Us
Filters
Showing results (21-30 of 47) with videos related to
Page
of 5
Sort By:
Biorxiv : the Preprint Server for Biology
|
November 28, 2024
Unbiased discovery of antibody therapies that stimulate macrophage-mediated destruction of B-cell lymphoma
Juliano Ribeiro, Carlota Pagès-Geli, Anna Meglan, et al.
Nature
|
September 21, 2010
Asterless is a scaffold for the onset of centriole assembly
Nikola S Dzhindzhev, Quan D Yu, Kipp Weiskopf, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 22, 2013
Anti-CD47 antibody-mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response
Diane Tseng, Jens-Peter Volkmer, Stephen B Willingham, et al.
Science Translational Medicine
|
December 24, 2010
Calreticulin is the dominant pro-phagocytic signal on multiple human cancers and is counterbalanced by CD47
Mark P Chao, Siddhartha Jaiswal, Rachel Weissman-Tsukamoto, et al.
The Journal of Clinical Investigation
|
March 14, 2024
Targeted therapies prime oncogene-driven lung cancers for macrophage-mediated destruction
Kyle Vaccaro, Juliet Allen, Troy W Whitfield, et al.
Science (New York, N.Y.)
|
June 1, 2013
Engineered SIRPα variants as immunotherapeutic adjuvants to anticancer antibodies
Kipp Weiskopf, Aaron M Ring, Chia Chi M Ho, et al.
Melanoma Research
|
June 18, 2019
Evolutionarily conserved resistance to phagocytosis observed in melanoma cells is insensitive to upregulation of pro-phagocytic signals and to CD47 blockade
Katie L Anderson, Kristin M Snyder, Daisuke Ito, et al.
Blood
|
January 4, 2011
CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies
Holbrook E Kohrt, Roch Houot, Matthew J Goldstein, et al.
Science Translational Medicine
|
August 12, 2016
Hematopoietic stem cell transplantation in immunocompetent hosts without radiation or chemotherapy
Akanksha Chhabra, Aaron M Ring, Kipp Weiskopf, et al.
The Journal of Clinical Investigation
|
June 4, 2019
Stimulation of natural killer cells with a CD137-specific antibody enhances trastuzumab efficacy in xenotransplant models of breast cancer
Holbrook E Kohrt, Roch Houot, Kipp Weiskopf, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 47) with videos related to
Sort By:
Page
of 5
Biorxiv : the Preprint Server for Biology
|
November 28, 2024
Unbiased discovery of antibody therapies that stimulate macrophage-mediated destruction of B-cell lymphoma
Juliano Ribeiro, Carlota Pagès-Geli, Anna Meglan, et al.
Nature
|
September 21, 2010
Asterless is a scaffold for the onset of centriole assembly
Nikola S Dzhindzhev, Quan D Yu, Kipp Weiskopf, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 22, 2013
Anti-CD47 antibody-mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response
Diane Tseng, Jens-Peter Volkmer, Stephen B Willingham, et al.
Science Translational Medicine
|
December 24, 2010
Calreticulin is the dominant pro-phagocytic signal on multiple human cancers and is counterbalanced by CD47
Mark P Chao, Siddhartha Jaiswal, Rachel Weissman-Tsukamoto, et al.
The Journal of Clinical Investigation
|
March 14, 2024
Targeted therapies prime oncogene-driven lung cancers for macrophage-mediated destruction
Kyle Vaccaro, Juliet Allen, Troy W Whitfield, et al.
Science (New York, N.Y.)
|
June 1, 2013
Engineered SIRPα variants as immunotherapeutic adjuvants to anticancer antibodies
Kipp Weiskopf, Aaron M Ring, Chia Chi M Ho, et al.
Melanoma Research
|
June 18, 2019
Evolutionarily conserved resistance to phagocytosis observed in melanoma cells is insensitive to upregulation of pro-phagocytic signals and to CD47 blockade
Katie L Anderson, Kristin M Snyder, Daisuke Ito, et al.
Blood
|
January 4, 2011
CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies
Holbrook E Kohrt, Roch Houot, Matthew J Goldstein, et al.
Science Translational Medicine
|
August 12, 2016
Hematopoietic stem cell transplantation in immunocompetent hosts without radiation or chemotherapy
Akanksha Chhabra, Aaron M Ring, Kipp Weiskopf, et al.
The Journal of Clinical Investigation
|
June 4, 2019
Stimulation of natural killer cells with a CD137-specific antibody enhances trastuzumab efficacy in xenotransplant models of breast cancer
Holbrook E Kohrt, Roch Houot, Kipp Weiskopf, et al.
Page
of 5